EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
24 08-2022

One week left to shape the programme of the Brain Innovation Days!

2022-08-31T12:11:43+00:0024-08-2022|News|

The Brain Innovation Days bring the brain ecosystem together to foster dialogue, exchange knowledge, accelerate investment in research & innovation and facilitate business development.  This year’s Brain Innovation Days event, to be held on 11-12 October 2022 in Brussels, will centre around “Connecting Brains”; bringing together the current and future generations of brain research and innovation.  Abstract submission [...]

2 08-2022

Sir Colin Blakemore (1944-2022): A Tribute

2022-08-02T15:37:05+00:0002-08-2022|News|

Neuroscientist, outstanding science communicator, advocate of animal rights, rationality and openness. The Observer described Blakemore as one of the UK's most influential scientists and a determined and courageous opponent of the violence of the animal rights movement. Colin, despite threats to himself and his family, including a parcel bomb opened by his children [...]

13 07-2022

Event Report: EBC at FENS Forum 2022

2022-07-18T13:07:38+00:0013-07-2022|News|

EBC was pleased to be back to another in-person congress last week, attending the FENS Forum on 9-13 July in Paris, France. EBC had a series of events throughout the five days, including a permanent stand in the Exhibition Hall, which brought a lot of interest and saw many EBC materials and giveaways distributed to [...]

23 06-2022

Preparing Europe for Novel Psychedelic-Assisted Therapies: PAREA officially launched on 23 June 2022

2022-06-24T10:24:15+00:0023-06-2022|News|

The Psychedelic Access and Research European Alliance – PAREA was officially launched today at a virtual event. Keynote Address was delivered by Dr Thomas Insel, former Director of the US National Institute of Mental Health (2002 – 2015). Other speakers included representatives from the European Parliament, European Commission, European Medicines Agency, patients and organizations representing [...]

Go to Top